Breast Aesthetics Company POLYTECH Reveals New Brand Identity at ISAPS Congress, Focusing on Translating Quality Standards Into a Tangible Experience

Food and Healthcare Press Releases Thursday November 1, 2018 15:36
DIEBURG, Germany--1 Nov--PRNewswire/InfoQuest
POLYTECH Health & Aesthetics GmbH, an international leader in Breast Aesthetics, announced today the launch of the new POLYTECH company branding and a new company website.

POLYTECH Health & Aesthetics GmbH launches its new brand image at the ISAPS (International Society of Aesthetic Plastic Surgeons) Congress this weekend in Miami, setting the course for international expansion of its market position as an innovation leader. The new branding to be officially launched at the POLYTECH booth, featuring further activities of augmented reality experience and the POLYTECH Lunch Symposium.

To view the Multimedia News Release, please click:
Innovation leader on course for international growth

The new branding reflects the company's growth strategy, expanding its global footprint and bringing Quality, Innovation and Commitment to surgeons and patients worldwide. With the largest breast implant portfolio on the market, in a variety of shapes, sizes and surfaces, POLYTECH caters to the specific preferences and needs of surgeons and patients, in both the aesthetic and reconstructive fields. Other products by the company include gluteal and body contouring implants.

POLYTECH's merger with G&G Biotechnology in July 2018, further strengthened the company's product portfolio with the innovative B-Lite(R), the first and only Lightweight Breast Implants in the world. Up to 30% lighter than traditional breast implants, B-Lite(R) implants combine well known and clinically proven materials in an innovative way to support natural fullness, feel and strength without the burden of extra weight.

Quality for the benefit of patients

"Our new tagline 'Quality you can feel' reflects the company culture, passion and commitment to quality in all that we do", stated Wolfgang Steimel, Polytech's CEO, and added: "With the largest breast implant portfolio on the market, and now with the most innovative breast implant B-Lite(R), we are committed to providing added value to our partners, customers and patients, with exceptional product quality and outstanding service. This innovation will be the perfect opportunity for POLYTECH to enter the US market."

"POLYTECH is in a unique position to bring its partners the most innovative products and a true commitment to quality, with the added value of financial stability. The new branding reflects the company's rising market position and its strategic decision to grow" concluded Tom Alzin, Managing Director, DBAG and POLYTECH Board member.

Expansion of digital corporate channels

The rebranding campaign focuses on the new website and the expansion of social media channels, optimizing our reach and engagement with partners, surgeons and patients. With over 280,000 social followers across the globe, POLYTECH is a leader in digital communication in the field of breast surgery.

The new website offers a clean, modern and mobile-responsive design, with easy navigation and helpful tools for partners, surgeons and patients. Visit the new website at
POLYTECH at a glance

With a global footprint in over 75 countries, POLYTECH Health & Aesthetics GmbH is an international leader in the development and production of silicone implants. Founded in 1986 in Dieburg, Germany, the company focuses on breast implants, used in both reconstructive and aesthetic plastic surgery. POLYTECH is the only German manufacturer of soft tissue implants. All products are developed exclusively at the company headquarters in Germany, and are manufacturedunder clean room conditions. The company employs over 250 people. For more information visit

* POLYTECH products are not sold in the US.
Media contact
dellian consulting gmbh
Karina Fritz und Margit Dellian
Hegelmaierstr. 24
74076 Heilbronn
Tel: +49-7131-7973-760
E-Mail: ;
(Photo: )
Source: POLYTECH Health & Aesthetics GmbH

Latest Press Release

Pivotal Phase III Data for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine

- JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for patients with advanced renal cell...

ISABS เตรียมจัดการประชุมว่าด้วยการแพทย์ส่วนบุคคลที่โครเอเชีย พร้อมเชิญเจ้าของรางวัลโนเบลร่วมบรรยาย

International Society for Applied Biological Sciences (ISABS) ร่วมกับ Mayo Clinic และ St. Catherine Hospital เตรียมจัดการประชุม "ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ครั้งที่ 11...

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine"(

Beijing Intellectual Property Court Confirms Judgment Against Wuxi Hisky Medical for Patent Infringement of Technology Used for Echosens# FibroScan(R), Imposes Damages Orders Halt to Manufacturing and Sales

Echosens, an innovative high-technology company offering the FibroScan family of products dedicated to assessment of chronic liver disease, today announces that the Beijing Intellectual Property Court has confirmed judgment against Wuxi Hisky Medical,...

5 Ways to Set Healthy Grocery Shopping Habits in 2019

By Susan Bowerman, M.S., RD, CSSD, CSOWM, FAN, Senior Director, Worldwide Nutrition Education and Training Make your daily staples as healthy as you can. Small changes in the foods you eat every day can add up to big rewards. The holidays are over, and...

Related Topics